Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models

Cell Stem Cell. 2021 Aug 31:S1934-5909(21)00338-6. doi: 10.1016/j.stem.2021.08.001. Online ahead of print.ABSTRACTIslet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but interventions to improve graft survival are needed. Here, we enhanced subcutaneous engraftment by employing a unique vascularization strategy based on ready-made microvessels (MVs) isolated from the adipose tissue. This resulted in improved cell survival and effective glucose response of both human islets and hESC-derived pancreatic cells, which ameliorated preexisting diabetes in three mouse models of T1D.PMID:34480863 | DOI:10.1016/j.stem.2021.08.001
Source: Cell Stem Cell - Category: Stem Cells Authors: Source Type: research

Related Links:

Cell Transplant. 2021 Jan-Dec;30:9636897211045320. doi: 10.1177/09636897211045320.ABSTRACTIn this Commentary, we echo the conclusions of a recent review titled "The promise of stem cell-derived islet replacement therapy," which highlighted recent advances in producing glucose responsive "islets" from stem cells and the benefits of their use in islet transplant therapy in type 1 diabetes (T1D). The review also outlined the status of clinical islet transplantation and the challenges that have prevented it from reaching its full therapeutic promise. We agree with the conclusions of the review and suggest t...
Source: Cell Transplantation - Category: Cytology Authors: Source Type: research
Toxicol Pathol. 2021 Sep 23:1926233211036395. doi: 10.1177/01926233211036395. Online ahead of print.ABSTRACTIslet-like clusters derived from human embryonic stem cells (hESC) hold the potential to cure type 1 diabetes mellitus. Differentiation protocols of islet-like clusters lead to the generation of minor fractions of nonendocrine cells, which are mainly from endodermal and mesodermal lineages, and the risk of implanting these is unclear. In the present study, the histogenesis and the tumorigenicity of nonendocrine cells were investigated in vivo. Immunodeficient mice were implanted under the kidney capsule with islet-li...
Source: Toxicologic Pathology - Category: Pathology Authors: Source Type: research
Pediatr Endocrinol Diabetes Metab. 2021;27(2):123-133. doi: 10.5114/pedm.2021.107165.ABSTRACTC-peptide, the molecule produced in an equimolar concentration to insulin, has become an established insulin secretion biomarker in diabetic patients. Measurement of C-peptide level can be helpful in clinical practice for assessing insulin-producing b-cells residual function, especially in the patients who have already started exogenous insulin therapy. Advances in assays have made measurement of C-peptide more reliable and inexpensive. Traditionally, C-peptide is widely used to differentiate between type 1, type 2 and monogenic ty...
Source: Pediatric Endocrinology, Diabetes, and Metabolism - Category: Endocrinology Authors: Source Type: research
Diabetes is a complex disease that affects over 400 million people worldwide. The life-long insulin injections and continuous blood glucose monitoring required in type 1 diabetes (T1D) represent a tremendous clinical and economic burdens that urges the need for a medical solution. Pancreatic islet transplantation holds great promise in the treatment of T1D; however, the difficulty in regulating post-transplantation immune reactions to avoid both allogenic and autoimmune graft rejection represent a bottleneck in the field of islet transplantation. Cell replacement strategies have been performed in hepatic, intramuscular, om...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 1 | Endocrinology | Pancreas | Stem Cell Therapy | Stem Cells | Transplants